Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sarah Melvin"'
Autor:
Sarah C. J. Jorgensen, Kyle P. Murray, Abdalhamid M. Lagnf, Sarah Melvin, Sahil Bhatia, Muhammad-Daniayl Shamim, Jordan R. Smith, Karrine D. Brade, Samuel P. Simon, Jerod Nagel, Karen S. Williams, Jessica K. Ortwine, Michael P. Veve, James Truong, David B. Huang, Susan L. Davis, Michael J. Rybak
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 1, Pp 89-106 (2020)
Abstract Background We sought to determine the real-world incidence of and risk factors for vancomycin-associated acute kidney injury (V-AKI) in hospitalized adults with acute bacterial skin and skin structure infections (ABSSSI). Methods Retrospecti
Externí odkaz:
https://doaj.org/article/b1972c958ffe464ba5f0ed226230571c
Autor:
Susan L. Davis, Sandra J Estrada, Sara Alosaimy, Sarah C J Jorgensen, Evan J Zasowski, Sahil Bhatia, Abdalhamid M Lagnf, Trang D Trinh, Molly E. Steed, Michael J. Rybak, Joshua R Rosenberg, Samuel Simon, Sarah Melvin
Publikováno v:
Open Forum Infectious Diseases
Background Ceftazidime–avibactam (CZA) is a novel cephalosporin/β-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant (MDR) Pseudomonas aeruginosa (PA). Real-world experience with CZA for
Autor:
Ryan P. Mynatt, Sahil Bhatia, Evan J Zasowski, Sarah Melvin, Sorabh Dhar, Sarah C J Jorgensen, Trang D Trinh, Sara Alosaimy, Michael J. Rybak, Jason M. Pogue
Publikováno v:
Open Forum Infectious Diseases
Background Combination β-lactam and vancomycin (VAN) prevent the emergence of resistance and result in synergistic antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) in vitro. We sought to provide clinical translation